← The Wire
LEGNNasdaq
Legend Biotech Corp
Pharmaceutical Preparations · E9 · CIK 1801198
Develops and commercializes cell therapies for cancer
⚡ Elevated coverage
$6.66B
Market cap
$29.39
Last close
+2.4%
1D
+0.2%
5D
1.3M
Volume
Price · last 39 sessions+10.9%
May 4L $25.51 · H $36.28Jun 29
204
Total filings
Jun 22, 2026
Last filing
12/31
Fiscal year end
6-K6-KJun 22, 2026424B5424B5Jun 18, 2026424B5424B5Jun 17, 20266-KFORM 6-KJun 15, 20266-KFORM 6-KJun 2, 20266-KFORM 6-KJun 1, 20266-KFORM 6-KMay 21, 20266-K6-KMay 12, 20266-KFORM 6-KApr 14, 202620-F20-FMar 10, 20266-KFORM 6-KMar 10, 20266-KFORM 6-KFeb 6, 20266-KFORM 6-KJan 23, 20266-KFORM 6-KJan 21, 20266-KFORM 6-KJan 14, 20266-KFORM 6-KJan 12, 20266-KFORM 6-KDec 8, 20256-K6-KNov 12, 20256-KFORM 6-KNov 3, 20256-KFORM 6-KOct 14, 20256-KFORM 6-KOct 14, 20256-KFORM 6-KOct 7, 20256-KFORM 6-KAug 18, 20256-K6-KAug 11, 20256-KFORM 6-KJul 16, 20256-KFORM 6-KJun 30, 20256-KFORM 6-KJun 12, 20256-KFORM 6-KJun 6, 20256-KFORM 6-KJun 5, 20256-KFORM 6-KJun 3, 20256-KFORM 6-KMay 23, 20256-KFORM 6-KMay 14, 20256-K6-KMay 13, 20256-K6-KMay 12, 20256-KFORM 6-KApr 15, 202520-F20-FMar 11, 20256-KFORM 6-KMar 11, 20256-KFORM 6-KJan 22, 20256-KFORM 6-KJan 14, 20256-KFORM 6-KDec 23, 20246-KFORM 6-KDec 10, 20246-K6-KNov 12, 20246-KFORM 6-KNov 5, 20246-K6-KOct 22, 20246-K6-KOct 21, 20246-KFORM 6-KOct 15, 20246-KFORM 6-KSep 27, 20246-K6-KSep 20, 20246-KFORM 6-KAug 27, 20246-K6-KAug 9, 20246-KFORM 6-KAug 8, 20246-KFORM 6-KJul 26, 20246-KFORM 6-KJul 17, 20246-KFORM 6-KJul 2, 20246-KFORM 6-KJun 3, 20246-KFORM 6-KMay 23, 20246-K6-KMay 13, 20246-KFORM 6-KApr 22, 20246-K6-KApr 16, 20246-K6-KApr 8, 20246-K6-KMar 29, 202420-F20-FMar 19, 20246-K6-KMar 15, 20246-K6-KMar 13, 20246-K6-KMar 11, 20246-K6-KFeb 23, 2024SC 13GSC 13GFeb 14, 2024SC 13GSC 13GJan 29, 20246-KLEGEND BIOTECH CORPORATION 6-KJan 23, 20246-KLEGEND BIOTECH CORPORATION 6-KJan 23, 20246-KLEGEND BIOTECH CORPORATION 6-KJan 9, 20246-KLEGEND BIOTECH CORPORATION 6-KDec 21, 20236-K6-KDec 21, 20236-KLEGEND BIOTECH CORPORATION 6-KDec 12, 20236-K6-KNov 20, 20236-KLEGEND BIOTECH CORP. 6-KNov 13, 20236-KLEGEND BIOTECH CORPORATION 6-KOct 17, 20236-K6-KSep 25, 20236-KLEGEND BIOTECH CORPORATION 6-KAug 28, 20236-K6-KAug 21, 2023
Insider Activity
In the 90 days to Jun 25, 2026: 1 sold $82K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 25, 2026 | Huang YingChief Executive Officer | Sell | 5,566 | $14.78 | $82K |
| Mar 25, 2026 | Huang YingChief Executive Officer | Sell | 9,936 | $8.77 | $87K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 1 reputable article · skews ▲ positive.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance